Induced Pluripotent Stem Cells (IPSCs) Research And Development
IPSCs have enormous applications in the field of regenerative medicine, disease modelling, and drug discovery. For the development of regenerative medicine, somatic cells from a diseased patient are used for the generation of iPSCs, which are then used for the regeneration of tissue-specific cells that can be transplanted into patients suffering from various types of degenerative diseases or injuries. Similarly, iPSCs based techniques are being successfully exploited for disease modelling, the study of some diseases, and for drug discovery, involving screening of small molecules, and testing of toxicity for assessment of safety.
The purpose of this whitepaper is to highlight the diverse applications of iPSCs, its various advantages, along with a general picture of the key companies that are developing iPSC-based therapies. The ongoing research on the capabilities of using iPSCs for modelling of various diseases, and in regenerative and personalized medicine, has brought revolutionary changes to medication.
Through this whitepaper, DelveInsight showcased a view of the current landscape of the applications of iPSCs and the advantages and challenges associated with iPSCs. The whitepaper also showcases a global glimpse of the significant companies offering iPSC research serves and products, along with a peek into industrial developments and technological advancements happening in the sphere of iPSCs.
